Literature DB >> 25344766

Association of restrictive ventilatory dysfunction with the development of prediabetes and type 2 diabetes in Koreans.

Chul-Hee Kim1, Hong-Kyu Kim, Eun-Hee Kim, Sung-Jin Bae, Young-Ju Jung, Jaewon Choi, Joong-Yeol Park.   

Abstract

AIMS: This study was performed to investigate whether ventilatory dysfunction is a predictor for the development of prediabetes and type 2 diabetes in Koreans.
METHODS: We analyzed the clinical and laboratory data of 16,195 Korean adults (age 20-79 years) who underwent routine medical checkups with a mean 4.7-years (range 3.0-5.9 years) interval. Spirometry results were categorized into three patterns: normal, obstructive ventilatory dysfunction [OVD; forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) <0.70], and restrictive ventilatory dysfunction (RVD; FVC < 80 % predicted, FEV1/FVC ≥ 0.70).
RESULTS: Compared with subjects with normal ventilatory function, subjects with RVD had a higher incidence of type 2 diabetes (3.7 vs. 6.3 %; P < 0.001), whereas subjects with OVD did not (3.7 vs. 4.8 %; P = 0.119). On multivariate logistic regression analysis, the odds ratio (OR) of RVD for type 2 diabetes was significantly increased after adjusting for age, sex, and lifestyle factors (1.40; 95 % CI 1.10-1.78). However, further adjustment for body mass index (BMI), waist circumference, and baseline glucose level attenuated the OR to become insignificant (1.12; 95 % CI 0.86-1.47). Among the 9,461 participants who had normal fasting glucose and HbA1c levels at baseline, the OR for progression to prediabetes or diabetes in the RVD group was significantly increased (1.30; 95 % CI 1.12-1.51). The increased OR remained significant after adjusting for BMI, waist circumference, and baseline glucose level (1.26; 95 % CI 1.07-1.47).
CONCLUSIONS: Our results indicate that restrictive, but not obstructive ventilatory dysfunction, is independently associated with development of prediabetes and precedes the development of type 2 diabetes.

Entities:  

Mesh:

Year:  2014        PMID: 25344766     DOI: 10.1007/s00592-014-0649-0

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  7 in total

1.  The temporal relationship between poor lung function and the risk of diabetes.

Authors:  Suneela Zaigham; Peter M Nilsson; Per Wollmer; Gunnar Engström
Journal:  BMC Pulm Med       Date:  2016-05-10       Impact factor: 3.317

Review 2.  Potential Biochemical Mechanisms of Lung Injury in Diabetes.

Authors:  Hong Zheng; Jinzi Wu; Zhen Jin; Liang-Jun Yan
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

3.  Adiponectin protects against lung ischemia-reperfusion injury in rats with type 2 diabetes mellitus.

Authors:  Di Li; Lin-Lin Song; Juan Wang; Chao Meng; Xiao-Guang Cui
Journal:  Mol Med Rep       Date:  2018-03-14       Impact factor: 2.952

4.  Qianjinweijing Decoction Protects Against Fine Particulate Matter Exposure-mediated Lung Function Disorder.

Authors:  Rucheng Chen; Jinna Zhang; Yaxian Pang; Qingping Liu; Jing Peng; Xiujuan Lin; Lingyong Cao; Weijia Gu; Lu Zhang; Ran Li; Qinghua Sun; Rong Zhang; Cuiqing Liu
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

5.  Association of pulse wave velocity with total lung capacity: A cross-sectional analysis of the BOLD London study.

Authors:  André F S Amaral; Jaymini Patel; Louisa Gnatiuc; Meinir Jones; Peter G J Burney
Journal:  Respir Med       Date:  2015-11-02       Impact factor: 3.415

6.  Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.

Authors:  Kei Nakajima
Journal:  J Clin Med Res       Date:  2020-05-08

7.  Chronic obstructive pulmonary disease, lung function and risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies.

Authors:  Yang Peng; Guo-Chao Zhong; Lingxiao Wang; Lijuan Guan; Ao Wang; Kai Hu; Jing Shen
Journal:  BMC Pulm Med       Date:  2020-05-11       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.